Access to anti-retroviral drugs, female in Eritrea

Eritrea: Access to anti-retroviral drugs, female was 72.0% in 2024. ◆ Volatile

Latest (2024)
72.0%
Change on year
unchanged
World rank
76th
of 141 countries
All-time high
72.0%
in 2023
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, female in Eritrea, 2000–2024

0204060802000201220242000: 0 %2001: 0 %2002: 0 %2003: 0 %2004: 0 %2005: 2 %2006: 5 %2007: 10 %2008: 14 %2009: 18 %2010: 25 %2011: 32 %2012: 37 %2013: 43 %2014: 50 %2015: 56 %2016: 58 %2017: 66 %2018: 68 %2019: 69 %2020: 71 %2021: 70 %2022: 71 %2023: 72 %2024: 72 %

Source: UNAIDS estimates. Measured in %.

Analysis

Eritrea recorded 72.0% for access to anti-retroviral drugs, female in 2024. That is the highest value across all 25 years on record.

Compared with earlier readings it is up 44.0% over ten years.

Over the whole period, access to anti-retroviral drugs, female in Eritrea peaked at 72.0% in 2023 and was at its lowest, 0.0%, in 2000.

Eritrea ranks 76th of 141 countries on this measure, in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, female in Eritrea, year by year

Annual values for Access to anti-retroviral drugs, female (%) in Eritrea, 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 0.0%
2004 0.0%
2005 2.0%
2006 5.0% +150.0%
2007 10.0% +100.0%
2008 14.0% +40.0%
2009 18.0% +28.6%
2010 25.0% +38.9%
2011 32.0% +28.0%
2012 37.0% +15.6%
2013 43.0% +16.2%
2014 50.0% +16.3%
2015 56.0% +12.0%
2016 58.0% +3.6%
2017 66.0% +13.8%
2018 68.0% +3.0%
2019 69.0% +1.5%
2020 71.0% +2.9%
2021 70.0% -1.4%
2022 71.0% +1.4%
2023 72.0% +1.4%
2024 72.0% +0.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 4.9% 0.0% 18.0% 10
2010s 50.4% 25.0% 69.0% 10
2020s 71.2% 70.0% 72.0% 5

Countries ranked near Eritrea

  1. 76 Canada 72.0% compare
  2. 76 Chad 72.0% compare
  3. 76 Georgia 72.0% compare
  4. 76 Viet Nam 72.0% compare

See the full ranking of 160 places →

More gender data for Eritrea

All data for Eritrea →

Frequently asked questions

What is access to anti-retroviral drugs, female in Eritrea?
Access to anti-retroviral drugs, female in Eritrea was 72.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, female recorded in Eritrea?
The highest recorded value was 72.0% in 2023.
What is the lowest access to anti-retroviral drugs, female recorded in Eritrea?
The lowest recorded value was 0.0% in 2000.
How does Eritrea rank for access to anti-retroviral drugs, female?
Eritrea ranks 76th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, female rising or falling in Eritrea?
Over the last ten years it is up 44.0%. The long-run trend across the full record is volatile.
Where does this Eritrea data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, female in Eritrea. Statizoid, drawing on UNAIDS estimates. Retrieved 06 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/eritrea/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/eritrea/">Access to anti-retroviral drugs, female in Eritrea</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, female (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,925 data points, 2000–2024
Last refreshed

The percentage of adult females living with HIV who are receiving antiretroviral therapy.